Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15746-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15746-1-AP, RRID:AB_2242461
- Product name
- ALDH3B2 antibody
- Antibody type
- Polyclonal
- Description
- ALDH3B2 antibody (Cat. #15746-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references β-Elemene inhibits epithelial-mesenchymal transformation in non-small cell lung cancer by targeting ALDH3B2/RPSA axis.
RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth.
Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma.
Loss-of-function of ALDH3B2 transdifferentiates human pancreatic duct cells into beta-like cells.
Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.
Zhou J, Kang Y, Gao Y, Ye XY, Zhang H, Xie T
Biochemical pharmacology 2025 Feb;232:116709
Biochemical pharmacology 2025 Feb;232:116709
RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth.
He J, Wang A, Zhao Q, Zou Y, Zhang Z, Sha N, Hou G, Zhou B, Yang Y, Chen T, Zhao Y, Jiang Y
Nature structural & molecular biology 2024 Sep;31(9):1413-1425
Nature structural & molecular biology 2024 Sep;31(9):1413-1425
Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma.
Jiménez R, Constantinescu A, Yazir M, Alfonso-Triguero P, Pequerul R, Parés X, Pérez-Alea M, Candiota AP, Farrés J, Lorenzo J
International journal of molecular sciences 2024 Oct 26;25(21)
International journal of molecular sciences 2024 Oct 26;25(21)
Loss-of-function of ALDH3B2 transdifferentiates human pancreatic duct cells into beta-like cells.
Li J, Bode K, Lee YC, Morrow N, Ma A, Wei S, da Silva Pereira J, Stewart T, Lee-Papastavros A, Hollister-Lock J, Sullivan B, Bonner-Weir S, Yi P
bioRxiv : the preprint server for biology 2024 May 15;
bioRxiv : the preprint server for biology 2024 May 15;
Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.
Wang Y, Li K, Zhao W, Liu Z, Liu J, Shi A, Chen T, Mu W, Xu Y, Pan C, Zhang Z
Cell death & disease 2021 Dec 14;12(12):1158
Cell death & disease 2021 Dec 14;12(12):1158
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- mouse lung tissue were subjected to SDS PAGE followed by western blot with 15746-1-AP(ALDH3B2 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of Hela cells, using ALDH3B2 antibody 15746-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human adrenal gland using 15746-1-AP(ALDH3B2 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human adrenal gland using 15746-1-AP(ALDH3B2 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue